HOME >> MEDICINE >> NEWS
NHLBI study shows vast majority of middle-aged Americans at risk of developing hypertension

Middle-aged Americans face a 90 percent chance of developing high blood pressure at some time during the rest of their lives, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI).

However, the study also had some good news for Americans: The risk of developing severe degrees of high blood pressure has decreased in the past 25 years, due partly to improved treatment.

The study, based on data from NHLBI's landmark Framingham Heart Study (FHS), appears in the February 27, 2002, issue of the Journal of the American Medical Association. The National Institute of Neurological Disorders and Stroke also contributed support to the research.

"Ninety percent is a staggering statistic and cause for concern," said Health and Human Services Secretary Tommy G. Thompson. "This finding should energize Americans to take steps to protect themselves against high blood pressure. By adopting some simple healthy behaviors, most people can reduce their risk of high blood pressure. Prevention gives people the power to protect their health."

"Americans have to better understand their risk of developing high blood pressure," agreed NHLBI Director Dr. Claude Lenfant. "They cannot adopt a wait and see approach. If they do, chances are they will find themselves with high blood pressure and that puts them at increased risk for heart disease and stroke.

"Fortunately," Lenfant continued, "high blood pressure is easily diagnosed and can be prevented by adopting certain lifestyle measuresdon't smoke, follow a healthy eating plan that includes foods lower in salt and sodium, maintain a healthy weight, be physically active, and if you drink alcoholic beverages, do so in moderation. For those who already have high blood pressure, it's important that they properly control it with these lifestyle measures and medication."

High blood pressure, or hypertension, is a measure of the force of blood within blood vessels. I
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
26-Feb-2002


Page: 1 2 3

Related medicine news :

1. NHLBI study shows smoking cessation programs improve survival
2. Frequent fast food meals increase weight, diabetes risk, NHLBI study says
3. NHLBI statement on oral contraceptive study
4. NHLBI stops sickle cell anemia transfusion study
5. Statement from Barbara Alving of NHLBI on guidelines for cardiovascular disease prevention in women
6. Former NHLBI director Lenfant receives Lifetime Achievement Award
7. NHLBI study finds hostility, impatience increase hypertension risk
8. NHLBI study finds moderate physical activity promotes weight loss as well as intense exercise
9. NHLBI funds new heart-health education projects in high-risk communities
10. NHLBI study shows weight concerns increase girls risk of becoming smokers
11. NHLBI-VA study finds no increased survival from beta-blocker for moderate to advanced heart failure

Post Your Comments:
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
Cached News: